New potent dual inhibitors of CK2 and Pim kinases: Discovery and structural insights (The FASEB Journal (2010) (3175) DOI: 10.1096/fj.09-143743)

New potent dual inhibitors of CK2 and Pim kinases: Discovery and structural insights (The FASEB Journal (2010) (3175) DOI: 10.1096/fj.09-143743)

Библиографические подробности
Главные авторы:	López-Ramos, M, Prudent, R, Moucadel, V, Sautel, C, Barette, C, Lafanechère, L, Mouawad, L, Grierson, D, Schmidt, F, Florent, J, Filippakopoulos, P, Bullock, A, Knapp, S, Reiser, J, Cochet, C
Формат:	Journal article
Опубликовано:	2011

Схожие документы

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights (September, pg 3175, 2010)
по: Lopez-Ramos, M, и др.
Опубликовано: (2011)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
по: López-Ramos, M, и др.
Опубликовано: (2010)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
по: López-Ramos, M, и др.
Опубликовано: (2010)

FASEB BioAdvances—Introductory editorial
по: Ralph A. Bradshaw
Опубликовано: (2019-06-01)

FASEB BioAdvances announces changes in 2024
по: Loren E. Wold, и др.
Опубликовано: (2024-04-01)

Q & A with FASEB BioAdvances Editors‐in‐Chief
по: Crislyn D'Souza‐Schorey, и др.
Опубликовано: (2022-08-01)

A brief history of FASEB and its programs and activities
по: Howard H. Garrison, и др.
Опубликовано: (2020-06-01)

LINC317.5 as a novel biomarker for hypertriglyceridemia in abnormal glucose metabolism
по: Yixue Yang, и др.
Опубликовано: (2024-04-01)

El factor de impacto de Nutrición Hospitalaria es 1,096 The impact factor of Nutrición Hospitalaria is 1.096
по: J. M. Culebras, и др.
Опубликовано: (2009-08-01)

HOXB1 Is a Tumor Suppressor Gene Regulated by miR-3175 in Glioma.
по: Liang Han, и др.
Опубликовано: (2015-01-01)

Prof dr FJ van Zyl as sendingteoloog
по: D. J.C. vanWyk
Опубликовано: (1989-01-01)

Publisher Correction: LINC317.5 as a novel biomarker for hypertriglyceridemia in abnormal glucose metabolism
по: Yixue Yang, и др.
Опубликовано: (2024-07-01)

[spa] “1096. LOS ORÍGENES DEL ANTISEMITISMO EN EUROPA”
по: José Eloy Hortal Muñoz
Опубликовано: (2014-12-01)

F.J. Lammers, Alexander. De vergeten kroonprins
по: C.A. Tamse
Опубликовано: (1981-01-01)

F.J. Lammers, Alexander. De vergeten kroonprins
по: C.A. Tamse
Опубликовано: (1981-01-01)

F.J. Lammers, Alexander. De vergeten kroonprins
по: C.A. Tamse
Опубликовано: (1981-01-01)

J.A. Coldeweij, De Heren van Kuyc 1096-1400
по: A.D.A. Monna
Опубликовано: (1985-01-01)

J.A. Coldeweij, De Heren van Kuyc 1096-1400
по: A.D.A. Monna
Опубликовано: (1985-01-01)

J.A. Coldeweij, De Heren van Kuyc 1096-1400
по: A.D.A. Monna
Опубликовано: (1985-01-01)

P1096: TREATMENT PATTERNS AND OUTCOMES IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA
по: A. Bock, и др.
Опубликовано: (2022-06-01)

Corrigendum to “Characterizing ruminal acidosis risk: A multiherd, multicountry study” (J. Dairy Sci. 106:3155–3175)
по: H.M. Golder, и др.
Опубликовано: (2024-04-01)

SG-APSIC1096: Changes in resistance patterns of “ESKAPE” pathogens to azithromincin and levofloxacin in Yogyakarta
по: Rizka Asdie, и др.
Опубликовано: (2023-02-01)

LncRNA LINC00520 Predicts Poor Prognosis and Promotes Progression of Lung Cancer by Inhibiting MiR-3175 Expression
по: Xia G, и др.
Опубликовано: (2020-07-01)

FJ Agroscience komersial baja kompos tahi arnab
по: Tarmizi, Liyana
Опубликовано: (2017)

Prof dr FJ van Zyl se Skrifbeskouing
по: P. A. Geyser
Опубликовано: (1989-01-01)

HADİSLERİN TEÂRUZUNDA SEM’ÂNÎ’NİN Ö. 489/1096 TAKİP ETTİĞİ TERCİH YÖNTEMLERİ
по: Mehmet Sait Uzundağ
Опубликовано: (2017-12-01)

DCAF1-targeting microRNA-3175 activates Nrf2 signaling and inhibits dexamethasone-induced oxidative injury in human osteoblasts
по: Jing Chen, и др.
Опубликовано: (2021-10-01)

Search for fJ(2220) in Radiative J/psi Decays
по: Dujmic, Denis, и др.
Опубликовано: (2011)

MARTÍNEZ, F.J.: Las ontologías de M. Foucault.
по: M. Díaz Marsá
Опубликовано: (1996-01-01)

Phenotypic Expression of Quantitative Characteristics in Fj Soya Hybrid Combinations
по: Л. Г. Білявська, и др.
Опубликовано: (2012-02-01)

Warriors and Civilians in the Crusade Movement. Military ldentities and Status in the Liberation and Defence of the Holy Land (1096-1204)
по: Alan V. Murray
Опубликовано: (2018-03-01)

The Federation of American Societies of Experimental Biology: A century of service and advocacyHowardGarrisonJudithBondRalphBradshawBethesda, MD: FASEB Press, 2019
по: Scheffler, Robin Wolfe
Опубликовано: (2021)

Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity.
по: Pogacic, V, и др.
Опубликовано: (2007)

Recrystallization and related annealing phenomena / F.J. Humphreys, M. Hatherly
по: 399097 Humphreys, F.J.
Опубликовано: (2004)

Prof dr FJ van Zyl as mens, kerkman en godsdiensfilosoof
по: P. J. van der Merwe
Опубликовано: (1989-01-01)

Martínez, F.J. [et al.]: "Spinoza: naturaleza, potencia y derecho"
по: Luciano Espinosa
Опубликовано: (2013-07-01)

Synthesis, kinase inhibitory potencies, and in vitro antiproliferative evaluation of new Pim kinase inhibitors.
по: Akué-Gédu, R, и др.
Опубликовано: (2009)

Comment on Mankowska et al. Critical Flicker Fusion Frequency: A Narrative Review. <i>Medicina</i> 2021, <i>57</i>, 1096
по: Xavier C. E. Vrijdag, и др.
Опубликовано: (2022-05-01)

Multicenter validation of PIM3 and PIM2 in Brazilian pediatric intensive care units
по: Daniel Hilário Santos Genu, и др.
Опубликовано: (2022-12-01)

P1096: TREATMENT OF HEPATITIS C-ASSOCIATED MARGINAL ZONE LYMPHOMA(HCV+LMZ) WITH DIRECT-ACTING ANTIVIRAL DRUGS (DAAS)
по: Sergey Lepkov, и др.
Опубликовано: (2023-08-01)